Novo Nordisk A/S (NVO)
NYSE: NVO · IEX Real-Time Price · USD
126.85
+1.06 (0.84%)
At close: Apr 26, 2024, 4:00 PM
127.30
+0.45 (0.35%)
After-hours: Apr 26, 2024, 7:59 PM EDT
Novo Nordisk Employees
Novo Nordisk had 64,319 employees on December 31, 2023. The number of employees increased by 9,134 or 16.55% compared to the previous year.
Employees
64,319
Change (1Y)
9,134
Growth (1Y)
16.55%
Revenue / Employee
$518,029
Profits / Employee
$186,645
Market Cap
550.22B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 64,319 | 9,134 | 16.55% |
Dec 31, 2022 | 55,185 | 6,707 | 13.84% |
Dec 31, 2021 | 48,478 | 3,155 | 6.96% |
Dec 31, 2020 | 45,323 | 2,065 | 4.77% |
Dec 31, 2019 | 43,258 | 56 | 0.13% |
Dec 31, 2018 | 43,202 | 520 | 1.22% |
Dec 31, 2017 | 42,682 | 711 | 1.69% |
Dec 31, 2016 | 41,971 | 1,333 | 3.28% |
Dec 31, 2015 | 40,638 | -319 | -0.78% |
Dec 31, 2014 | 40,957 | 2,521 | 6.56% |
Dec 31, 2013 | 38,436 | 3,705 | 10.67% |
Dec 31, 2012 | 34,731 | 2,099 | 6.43% |
Dec 31, 2011 | 32,632 | 2,149 | 7.05% |
Dec 31, 2010 | 30,483 | 1,154 | 3.93% |
Dec 31, 2009 | 29,329 | 2,754 | 10.36% |
Dec 31, 2008 | 26,575 | 1,059 | 4.15% |
Dec 31, 2007 | 25,516 | 1,903 | 8.06% |
Dec 31, 2006 | 23,613 | 1,153 | 5.13% |
Dec 31, 2005 | 22,460 | 1,735 | 8.37% |
Dec 31, 2004 | 20,725 | 1,969 | 10.50% |
Dec 31, 2003 | 18,756 | 751 | 4.17% |
Dec 31, 2002 | 18,005 | 1,864 | 11.55% |
Dec 31, 2001 | 16,141 | 2,389 | 17.37% |
Dec 31, 2000 | 13,752 | 1,758 | 14.66% |
Dec 31, 1999 | 11,994 | 345 | 2.96% |
Dec 31, 1998 | 11,649 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Danaher | 63,000 |
NVO News
- 3 days ago - Senate launches investigation into high prices of Ozempic and Wegovy in the U.S. - CNBC
- 3 days ago - US Senate committee investigates pricing of Novo's Ozempic and Wegovy - Reuters
- 3 days ago - Novo Nordisk A/S - Articles of Association, April 2024 - GlobeNewsWire
- 3 days ago - Novo Nordisk A/S – Reduction of the share capital - GlobeNewsWire
- 5 days ago - Novo Nordisk A/S - share repurchase programme - GlobeNewsWire
- 9 days ago - Eight stock picks in AI, obesity drugs, e-commerce and other growth areas beyond the S&P 500 - Market Watch
- 9 days ago - German watchdog approves Novo's acquisition of Cardior Pharmaceuticals - Reuters
- 11 days ago - Big pharma is looking to fatten profits with buyouts of weight-loss drug companies. Here are 4 candidates. - Market Watch